Veracyte Inc (VCYT):企業の財務・戦略的SWOT分析

◆英語タイトル:Veracyte Inc (VCYT) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14736
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The company’s pipeline products include Afirma thyroid FNA analysis for the diagnosis of thyroid cancer based on its proprietary afirma gene expression classifier. It also provides percepta bronchial genomic classifier an assay to evaluate patients with lung nodules that are suspected for cancer. Veracyte provides genomic testing to other areas of substantial clinical need with diagnostic ambiguity. The company markets its afirma solutions through its sales force across in the US. It also commercializes its products in Brazil. Veracyte is headquartered in South San Francisco, California, the US.

Veracyte Inc Key Recent Developments

Feb 25,2019: Veracyte announces fourth quarter and full-year 2018 financial results and provides 2019 financial outlook
Jan 04,2019: J&J and Veracyte alliance to focus on lung cancer diagnostics
Nov 08,2018: Veracyte Announces Publication of Data Demonstrating Real World Performance of Afirma GSC in Thyroid Cancer Diagnosis
Oct 29,2018: Veracyte reports third quarter 2018 financial results
Oct 08,2018: Veracyte Announces Presentation of Data Confirming Envisia Genomic Classifier’s Ability to Improve Diagnosis of Idiopathic Pulmonary Fibrosis

This comprehensive SWOT profile of Veracyte Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Veracyte Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Veracyte Inc – Key Information
Veracyte Inc – Overview
Veracyte Inc – Key Employees
Veracyte Inc – Key Employee Biographies
Veracyte Inc – Key Operational Heads
Veracyte Inc – Major Products and Services
Veracyte Inc – History
Veracyte Inc – Company Statement
Veracyte Inc – Locations And Subsidiaries
Veracyte Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Veracyte Inc – Business Description
Veracyte Inc – Corporate Strategy
Veracyte Inc – SWOT Analysis
SWOT Analysis – Overview
Veracyte Inc – Strengths
Veracyte Inc – Weaknesses
Veracyte Inc – Opportunities
Veracyte Inc – Threats
Veracyte Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Veracyte Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Veracyte Inc, Key Information
Veracyte Inc, Key Ratios
Veracyte Inc, Share Data
Veracyte Inc, Major Products and Services
Veracyte Inc, History
Veracyte Inc, Key Employees
Veracyte Inc, Key Employee Biographies
Veracyte Inc, Key Operational Heads
Veracyte Inc, Other Locations
Veracyte Inc, Subsidiaries
Veracyte Inc, Key Manufacturing facilities
Veracyte Inc, Key Competitors
Veracyte Inc, SWOT Analysis
Veracyte Inc, Ratios based on current share price
Veracyte Inc, Annual Ratios
Veracyte Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Veracyte Inc, Performance Chart
Veracyte Inc, Ratio Charts

★海外企業調査レポート[Veracyte Inc (VCYT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GCL System Integration Technology Co Ltd (002506):電力:M&Aディール及び事業提携情報
    Summary GCL System Integration Technology Co Ltd (GCL System Integration), formerly Shanghai Chaori Solar Energy Science & Technology Co Ltd, a subsidiary of Golden Concord Holdings Ltd, is a renewable energy company that offers clean and sustainable power production services. The company's products …
  • Oman Cables Industry (OCAI):企業の財務・戦略的SWOT分析
    Oman Cables Industry (OCAI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Farbest-Tallman Foods Corp.:企業の戦略・SWOT・財務分析
    Farbest-Tallman Foods Corp. - Strategy, SWOT and Corporate Finance Report Summary Farbest-Tallman Foods Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • RedHill Biopharma Ltd (RDHL):企業の財務・戦略的SWOT分析
    RedHill Biopharma Ltd (RDHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Fluxys SA:企業の戦略的SWOT分析
    Fluxys SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Neuraltus Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Neuraltus Pharmaceuticals Inc (Neuraltus) is a biopharmaceutical company that develops and commercializes therapeutics for the treatment of neurodegenerative diseases. The company offers products under clinical development that include NP001 and others. Neuraltus’ focuses on macrophage which …
  • Aviragen Therapeutics Inc (AVIR)-製薬・医療分野:企業M&A・提携分析
    Summary Aviragen Therapeutics Inc (Aviragen) is a pharmaceutical company that carries out anti-infective drug discovery, development and its commercialization to treat respiratory diseases. It has four product candidates in clinical development which address viral infections, namely, vapendavir, ora …
  • Biocurv Medical Instruments, Inc.:企業の戦略・SWOT・財務情報
    Biocurv Medical Instruments, Inc. - Strategy, SWOT and Corporate Finance Report Summary Biocurv Medical Instruments, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Morphotek Inc-製薬・医療分野:企業M&A・提携分析
    Summary Morphotek Inc (Morphotek), a subsidiary of Eisai Co Ltd is a clinical-stage biotech company that develops novel classes of biological based products. The company offers a pipeline of monoclonal antibodies, antibody drug conjugates, and bispecific antibodies for the treatment of cancer, infla …
  • Atlas Genetics Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Atlas Genetics Ltd (Atlas Genetics) is an in vitro diagnostics company that offers decentralised, near-patient and point of care testing services. The company develops and offers diagnostic platforms such as io system and callisto system. Its io system is a diagnostic instrument and disposab …
  • Transmissora Alianca de Energia Eletrica SA (TAEE11):企業の財務・戦略的SWOT分析
    Transmissora Alianca de Energia Eletrica SA (TAEE11) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • NorgesGruppen ASA:企業の戦略的SWOT分析
    NorgesGruppen ASA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Analog Devices, Inc.:企業のM&A・事業提携・投資動向
    Analog Devices, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Analog Devices, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Invivo Corp:医療機器:M&Aディール及び事業提携情報
    Summary Invivo Corp (Invivo), a subsidiary of Koninklijke Philips NV is a medical device company that designs, manufactures, and markets patient monitoring systems. The company offers products in various categories such as advanced visualization systems, breast imaging and biopsy solutions, neuro im …
  • Deutsche Apotheker- und Arztebank:企業の戦略・SWOT・財務分析
    Deutsche Apotheker- und Arztebank - Strategy, SWOT and Corporate Finance Report Summary Deutsche Apotheker- und Arztebank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Leonardo SpA (LDO):企業の財務・戦略的SWOT分析
    Leonardo SpA (LDO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Enerjisa Enerji AS (ENJSA):企業の財務・戦略的SWOT分析
    Enerjisa Enerji AS (ENJSA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Wotif.com Holdings Limited:企業の戦略・SWOT・財務分析
    Wotif.com Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Wotif.com Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Macrogen Inc (038290):企業の財務・戦略的SWOT分析
    Macrogen Inc (038290) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Concurrent Technologies Corporation:企業の戦略・SWOT・財務情報
    Concurrent Technologies Corporation - Strategy, SWOT and Corporate Finance Report Summary Concurrent Technologies Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆